WHO ICTRP trial
Comparison of hypofractionated helical tomotherapy (TOMO) concurrent…
ChiCTR1800017367 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1800017367 |
|---|---|
| Public title | Comparison of hypofractionated helical tomotherapy (TOMO) concurrent chemoradiation therapy versus conventional intensity-modulated radiation therapy concurrent chemoradiation therapy for the inoperable stage III non-small cell lung cancer: a prospective, randomized, multicenter controlled trial |
| Scientific title | Comparison of hypofractionated helical tomotherapy (TOMO) concurrent chemoradiation therapy versus conventional intensity-modulated radiation therapy concurrent chemoradiation therapy for the inoperable stage III non-small cell lung cancer: a prospective, randomized, multicenter controlled trial |
| Primary sponsor | Zhongshan Hospital, Fudan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | III (Phase III study) |
| Countries | China |
| Conditions | III non-small cell lung cancer |
| Interventions | Group 1:TOMO;Group 2:IMRT |
| Registration date | Jul 26, 2018 |
| Target size | Group 1:162;Group 2:162 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: